NEIL KUMAR - 16 Nov 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: CEO and President, Director
Signature: /s/ Yi Ching Yau, Attorney in Fact
Issuer symbol: BBIO
Transactions as of: 16 Nov 2021
Net transactions value: -$176,242
Form type: 4
Filing time: 18 Nov 2021, 15:05:25 UTC
Previous filing: 09 Nov 2021
Next filing: 07 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Options Exercise		+7,523	+0.16%		4,726,534	16 Nov 2021	Direct	F1
transaction	BBIO	Common Stock	Tax liability	$176,242	-3,730	-0.08%	$47.25	4,722,804	16 Nov 2021	Direct	F2
holding	BBIO	Common Stock						1,612,722	16 Nov 2021	See Footnote	F3
holding	BBIO	Common Stock						1,195,686	16 Nov 2021	See Footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-5,129	-9.1%	$0.000000	51,294	16 Nov 2021	Common Stock	5,129		Direct	F1, F5
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-2,394	-7.1%	$0.000000	31,124	16 Nov 2021	Common Stock	2,394		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 7,523 shares of Common Stock underlying the Reporting Person's RSUs.
F3	The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4	The shares are held by Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F5	The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F6	The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.